Par Drugs and Chemicals Limited (PAR)

235.4

INR
+11.45(+5.11%)
As of December 6, 2024 9:59:00 AM

Par Drugs and Chemicals Limited Share Price Information

24 hour Low and High

Low: 223.95
High: 248.7

All time High

9132.13

Price Change 1h

+₹8.75 +3.86%

Price Change 1d

+₹8.75 +3.86%

Price Change 1w

+₹-35.70 +-13.17%

Par Drugs and Chemicals Limited Market Information

Exchange

NSE

Market Cap

360.78 Cr

About Par Drugs and Chemicals Limited Share

Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, and synthetic aluminium silicate. It offers fine chemicals, such as precipitated silica, sodium aluminium silicate, amorphous aluminium hydroxide, PARSIL-HT, PAR ADD OP, MagSil OF, FlowSil, aluminium hydroxide magnesium carbonate co-dried gel, magnesium aluminium silicate hydrated (pharma), and magnesium aluminium silicate hydrated (agro). It exports its products to Germany, the United Kingdom, Bangladesh, Iran, the United Arab Emirates, Indonesia, Japan, South Korea, and internationally. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

122

CEO

Mr. Jignesh Vallabhbhai Savani

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Par Drugs & Chemicals Ltd: Microcap Company Shines in Stock Market with Record High Performance
  • Par Drugs and Chemicals Insiders Benefitted From Selling Stock At ₹224
  • Par Drugs and Chemicals: A cautionary tale for micro cap investing
  • Pharma stock hits 20% upper circuit after Co. to venture into real estate business
  • Stock market update: Stocks that hit 52-week highs on NSE

FAQs

Par Drugs and Chemicals Limited (PAR)

235.4

INR
+11.45(+5.11%)
As of December 6, 2024 9:59:00 AM

Par Drugs and Chemicals Limited Share Price Information

24 hour Low and High

Low: 223.95
High: 248.7

All time High

9132.13

Price Change 1h

+₹8.75 +3.86%

Price Change 1d

+₹8.75 +3.86%

Price Change 1w

+₹-35.70 +-13.17%

Par Drugs and Chemicals Limited Market Information

Exchange

NSE

Market Cap

360.78 Cr

About Par Drugs and Chemicals Limited Share

Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, and synthetic aluminium silicate. It offers fine chemicals, such as precipitated silica, sodium aluminium silicate, amorphous aluminium hydroxide, PARSIL-HT, PAR ADD OP, MagSil OF, FlowSil, aluminium hydroxide magnesium carbonate co-dried gel, magnesium aluminium silicate hydrated (pharma), and magnesium aluminium silicate hydrated (agro). It exports its products to Germany, the United Kingdom, Bangladesh, Iran, the United Arab Emirates, Indonesia, Japan, South Korea, and internationally. Par Drugs and Chemicals Limited was founded in 1982 and is based in Vadodara, India.

Sector

Healthcare

Drug Manufacturers - Specialty & Generic

Employees

about

122

CEO

Mr. Jignesh Vallabhbhai Savani

Revenue (2023)

%

Country of Origin

India

Key Highlights

  • Par Drugs & Chemicals Ltd: Microcap Company Shines in Stock Market with Record High Performance
  • Par Drugs and Chemicals Insiders Benefitted From Selling Stock At ₹224
  • Par Drugs and Chemicals: A cautionary tale for micro cap investing
  • Pharma stock hits 20% upper circuit after Co. to venture into real estate business
  • Stock market update: Stocks that hit 52-week highs on NSE

FAQs